Is the burden of Staphylococcus aureus among patients with surgical-site infections growing?
Jernigan
John A
JA
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D006761:Hospitals / Q000706:statistics & numerical data; D006801:Humans; D017053:Infection Control / Q000379:methods; D016106:Methicillin Resistance; D008875:Middle Aged; D016712:Mupirocin / Q000494:pharmacology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology*; D013211:Staphylococcus aureus / Q000187:drug effects / Q000472:pathogenicity; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D016712:Mupirocin